Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US-2025367188-A1 · Dec 4, 2025 · US
This page is not indexed by search engines while we improve data quality.
Leadbetter Michael patents
Leadbetter Michael is listed as an inventor on 15 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Leadbetter Michael |
| Total patents | 15 |
| First publication | Oct 22, 2015 |
| Latest publication | Dec 4, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Compounds and methods for treating hyperkalemia
US-2025067907-A1 · Feb 27, 2025 · US
Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US-2024366590-A1 · Nov 7, 2024 · US
Compounds and methods for treating hyperkalemia
US-2024209019-A1 · Jun 27, 2024 · US
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US-12016856-B2 · Jun 25, 2024 · US
Glycyrrhetinic acid derivatives for use in treating hyperkalemia
US-11858959-B2 · Jan 2, 2024 · US
Glycyrrhetinic acid derivatives for treating hyperkalemia
US-11768319-B2 · Sep 26, 2023 · US
Glycyrrhetinic acid derivatives for treating hyperkalemia
US-2023273354-A1 · Aug 31, 2023 · US
Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US-2023031776-A1 · Feb 2, 2023 · US
Glycyrrhetinic acid derivatives for use in treating hyperkalemia
US-2022106354-A1 · Apr 7, 2022 · US
Recent patents
Latest publications not already listed above.
Glycyrrhetinic acid derivatives for treating hyperkalemia
US-2021163524-A1 · Jun 3, 2021 · US
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US-10385024-B2 · Aug 20, 2019 · US
Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US-2019062279-A1 · Feb 28, 2019 · US
Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US-2015336892-A1 · Nov 26, 2015 · US
Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US-2015299131-A1 · Oct 22, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Ardelyx Inc | 17 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P3/12 | 8 |
| A61K45/06 | 8 |
| A61K47/60 | 8 |
| A61K31/58 | 7 |
| C07J63/008 | 7 |